DRGEM Corporation Market Cap ($35.96 Million)
Market Cap & Net Worth: DRGEM Corporation (263690)
DRGEM Corporation market cap. DRGEM Corporation (KQ:263690) has a market capitalization of $35.96 Million (₩53.06 Billion) as of November 5, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #22910 globally and #1526 in its home market, demonstrating a 0.31% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying DRGEM Corporation's stock price ₩4870.00 by its total outstanding shares 10895516 (10.90 Million). Also see DRGEM Corporation (263690) cash conversion ratio for how efficiently the company converts equity into cash flow.
DRGEM Corporation Market Cap History (2018–2026)
DRGEM Corporation market cap history from 2018 to 2026. Data shows change from $46.14 Million to $35.96 Million (-2.83% CAGR). Check 263690 live share price for real-time trading data and today's change.
Index Memberships
DRGEM Corporation is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$203.83 Billion | 0.02% | #752 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$203.83 Billion | 0.02% | #752 of 1384 |
Weight: DRGEM Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
DRGEM Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how DRGEM Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore DRGEM Corporation net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
DRGEM Corporation's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
DRGEM Corporation's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $46.14 Million | $56.63 Billion | $4.65 Billion | 0.00x | 0.01x |
| 2019 | $56.53 Million | $60.09 Billion | $5.47 Billion | 0.00x | 0.01x |
| 2020 | $116.69 Million | $106.60 Billion | $19.99 Billion | 0.00x | 0.01x |
| 2021 | $83.34 Million | $85.75 Billion | $12.55 Billion | 0.00x | 0.01x |
| 2022 | $75.90 Million | $110.17 Billion | $14.39 Billion | 0.00x | 0.01x |
| 2023 | $76.86 Million | $112.92 Billion | $9.19 Billion | 0.00x | 0.01x |
| 2024 | $41.94 Million | $104.01 Billion | $10.15 Billion | 0.00x | 0.00x |
| 2025 | $39.43 Million | $102.75 Billion | $6.78 Billion | 0.00x | 0.01x |
Competitor Companies of 263690 by Market Capitalization
Companies near DRGEM Corporation in the global market cap rankings as of November 5, 2026. Also see DRGEM Corporation total assets for a full breakdown of the balance sheet.
Key companies related to DRGEM Corporation by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $190.23 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $119.12 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #226 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $190.23 Billion | $109.40 |
| #204 | Stryker Corporation | NYSE:SYK | $119.12 Billion | $310.55 |
| #226 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $98.88 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of DRGEM Corporation (2018–2026)
Market capitalization of DRGEM Corporation from 2018 to today. Between 2018 and today, DRGEM Corporation's market cap moved from $46.14 Million to $ 35.96 Million, with a yearly change of -2.83%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩35.96 Million | -8.80% |
| 2025 | ₩39.43 Million | -5.99% |
| 2024 | ₩41.94 Million | -45.44% |
| 2023 | ₩76.86 Million | +1.27% |
| 2022 | ₩75.90 Million | -8.93% |
| 2021 | ₩83.34 Million | -28.58% |
| 2020 | ₩116.69 Million | +106.42% |
| 2019 | ₩56.53 Million | +22.53% |
| 2018 | ₩46.14 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of DRGEM Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $35.96 Million USD |
| MoneyControl | $35.96 Million USD |
| MarketWatch | $35.96 Million USD |
| marketcap.company | $35.96 Million USD |
| Reuters | $35.96 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About DRGEM Corporation
DRGEM Corporation manufactures and sells diagnostic radiography systems. It offers high frequency X-ray generators; conventional and digital radiography systems; and ACQUIDR, a digital imaging system. DRGEM Corporation exports its products. The company was founded in 2003 and is headquartered in Gwangmyeong-si, South Korea.